What Hyperhomocysteinemia Does
Hyperhomocysteinemia increases the risk of atherosclerotic vascular disease 2- to 3-fold, including stroke, myocardial infarction, and both arterial and venous thrombosis, though a direct causal relationship remains unproven. 1
Cardiovascular and Cerebrovascular Effects
Elevated plasma homocysteine levels are strongly associated with:
- Stroke risk: Each 5 μmol/L increase in homocysteine raises stroke risk by 59% (95% CI, 29% to 96%), while each 3 μmol/L decrease reduces stroke risk by 24% (95% CI, 15% to 33%) 1
- Atherosclerotic disease: Increased carotid intima-media thickness (IMT) and carotid artery stenosis 1
- Coronary artery disease: Meta-analyses attribute up to 10% of coronary disease risk to hyperhomocysteinemia 2
- Thrombotic events: Both arterial and venous occlusions, including deep venous thrombosis 3
Important caveat: Several recent investigations found that the relationship between homocysteine and carotid IMT disappeared after adjusting for other cardiovascular risk factors or renal function, suggesting homocysteine may be a marker rather than a direct cause 1.
Mechanisms of Vascular Damage
Hyperhomocysteinemia damages the vasculature through multiple pathways 4, 5:
- Oxidative stress: Generation of reactive oxygen species during homocysteine oxidation to homocystine
- Endothelial dysfunction: Impaired nitric oxide bioavailability and eNOS uncoupling
- Pro-thrombotic state: Inhibition of thrombomodulin, increased tissue factor expression, and impaired fibrinolysis
- Protein modification: Formation of homocysteine-thiolactone adducts that damage proteins and enzymes 6
- Inflammatory responses: Increased pro-inflammatory cytokines and downregulation of anti-inflammatory cytokines 5
Systemic Manifestations
Beyond cardiovascular disease, hyperhomocysteinemia is associated with:
- Neurological: Mental retardation (in homocystinuria type I), seizures, Alzheimer's disease, depression 3, 7
- Ocular: Ectopia lentis, secondary glaucoma, optic atrophy, retinal detachment 3, 6
- Skeletal: Marfanoid appearance, osteoporosis 3, 6
- Renal: Chronic kidney disease both causes and is worsened by hyperhomocysteinemia 1
- Pregnancy complications: Placental abruptions, neural tube defects 8
Special Populations
In dialysis patients: Prevalence reaches 85-100%, with concentrations ranging from 20.4-68.0 μmol/L. The severe elevations may contribute to the 50% cardiovascular mortality rate in this population 9.
In children: Hyperhomocysteinemia is an independent risk factor for cerebral arterial or venous thrombosis and rapidly progressive arteriosclerotic vascular disease 3.
Critical Evidence Gap
Despite strong observational associations, randomized controlled trials have consistently failed to show that lowering homocysteine with B-vitamin supplementation (folic acid, B6, B12) reduces cardiovascular events. The VISP, VITATOPS, and other major trials showed no benefit on clinical endpoints despite successfully lowering homocysteine levels 1. This suggests homocysteine may be a marker of vascular disease rather than a direct cause, or that other homocysteine metabolites (like homocysteine-thiolactone) not affected by vitamin therapy are the true culprits 10.
Clinical Significance in 2025
The current evidence indicates hyperhomocysteinemia is best viewed as a risk marker rather than a modifiable risk factor, particularly in patients with established cardiovascular disease, renal failure, or diabetes where it strongly predicts vascular morbidity and mortality 8, 10. The controversy persists, and routine screening or treatment to lower homocysteine for cardiovascular prevention is not supported by high-quality evidence 10.